封面
市場調查報告書
商品編碼
1830974

血壓監測設備市場

Blood Pressure Monitoring Devices Market

出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

預計血壓監測設備市場將從 2024 年的 29.1 億美元擴大到 2031 年的 59 億美元,2025 年至 2031 年的複合年成長率預計為 10.6%。

市場洞察與分析師觀點:血壓監測設備對於識別患者的高血壓至關重要。高血壓是中風和慢性心臟病的重要風險因素,而中風和慢性心臟病是全球死亡的主要原因。近年來,家庭護理環境中血壓監測設備的採用率顯著增加。此外,人口老化、生活方式的改變和技術創新等因素也是血壓監測設備市場成長的關鍵因素。這些設備能夠及早發現患者的健康狀況惡化。此外,先進的個人血壓監測儀還可以實現遠端健康追蹤。

成長催化劑:心血管疾病發病率上升推動血壓監測設備市場成長過去十年,血壓監測設備的重大進步為患者和醫療保健提供者提供了管理各種疾病的創新方法,包括室性和房性心律不整以及室性心房顫動。心臟驟停、冠心病、先天性心臟缺陷、肺動脈高壓、心臟衰竭和肺動脈壓升高 (PA) 等心血管疾病 (CVD) 的盛行率不斷上升,支持了增強監測技術的發展。易於使用和快速檢測異常是血壓監測設備的關鍵優勢。根據世界衛生組織 (WHO) 的數據,每年約有 3000 萬人中風。美國心臟協會預測,到 2035 年,美國將有超過 1.3 億人患有某種形式的心血管疾病。

歐洲心臟學會報告稱,心房顫動是最常見的心律不整疾病,佔歐洲醫療支出的0.28%至2.6%。報告也指出,心房顫動患者的中風風險增加五倍,歐洲所有中風病例中有20%至30%與心房顫動有關。歐洲心臟學會 2016 年的一項研究發現,歐盟約有 760 萬 65 歲及以上人士患有心房顫動,預計到 2060 年,這一數字將上升 89%,達到約 1,440 萬。心房顫動的盛行率預計將從 2016 年的 7.8% 上升到 2060 年的 9.5%。根據 Biosense Webster 2019 年的一份題為「心房顫動對亞太地區的影響」的報告,亞太地區約有 1,600 萬人患有心房顫動,預計到 2050 年,這一數字將上升到近 7,200 萬。報告強調,中老年族群罹患此病的風險更高。

策略洞察報告細分和範圍:「血壓監測設備市場」根據產品、類型和最終用戶進行分類。就產品而言,市場包括水銀柱血壓計、無液體血壓計和電子血壓計。就類型而言,市場分為臂式、腕式、指套式和其他類型。就最終用戶而言,市場細分為醫院和診所、家庭護理機構、門診手術中心和其他類型。

細分分析:就產品而言,血壓監測設備市場分為水銀柱血壓計、無液體血壓計和電子血壓計。 2022 年,數位血壓計市場佔據了相當大的市場佔有率,預計在 2022 年至 2030 年期間將呈現最快的複合年成長率。數位血壓計旨在精確測量血壓和脈搏。它們通常比無液血壓計更易於操作,將聽診器和儀表整合在一個單元中,並帶有錯誤指示器。血壓讀數顯示在小螢幕上,比傳統的錶盤更容易讀取。數位血壓計對聽障患者特別有益,因為他們不需要透過聽診器聽心跳。

按類型分類,血壓監測設備市場分為手臂式、腕式、手指式和其他類型。 2022 年,手臂式佔據了最大的市場佔有率,預計在 2022 年至 2030 年期間將以最快的複合年成長率成長。基於手指的血壓監測技術的工作原理與脈搏血氧儀類似,利用從使用者手指反射的光,透過光電容積圖 (PPG) 評估血流,並由各種演算法進行解讀。 2023 年 5 月,加州大學聖地牙哥分校的工程師推出了一款低成本夾子,它使用智慧型手機的相機和閃光燈在指尖測量血壓。這款設備與客製化應用程式配合使用,目前的生產成本約為 80 美分,規模化後成本可能降至每台 10 美分。這項創新旨在簡化常規血壓監測,使其變得經濟實惠且易於獲取,尤其對於控制高血壓的老年人和孕婦。

就最終用戶而言,血壓監測設備市場細分為醫院和診所、家庭護理機構、門診手術中心等。 2022 年,醫院和診所佔據了相當大的市場佔有率,而預計家庭護理機構在 2022 年至 2030 年期間的複合年成長率最快。醫院和診所是許多地區的主要醫療保健提供者。美國心臟協會報告稱,中老年人心律不整的盛行率很高。心房顫動、緩慢性心律不整和傳導系統疾病等疾病佔心律不整病例的多數。例如,在美國,心律不整影響至少 230 萬人,增加了中風和死亡的風險。此外,美國每年診斷出 90,000 例室上性心搏過速,佔所有此類急診就診人數的 25%。 NCBI 報告顯示,在 5,585 例因心律不整入院的患者中,有 2,020 例(36.1%)同時存在心律不整。因此,多專科醫院數量的不斷成長,以及人們對醫院和診所而非其他醫療機構的偏好,促進了該領域血壓監測設備市場的擴張。

區域分析:從地理來看,全球血壓監測設備市場分為亞太地區、歐洲、中東和非洲、北美以及南美和中美。 2022年,北美佔據全球血壓監測設備市場的最大佔有率,而亞太地區預計將在2022年至2030年期間實現最高的複合年成長率。

北美血壓監測設備市場涵蓋美國、加拿大和墨西哥。該地區市場的成長受到許多因素的推動,例如心臟病發病率的上升,以及旨在打造創新基於感測器的患者監測系統的持續研發。此外,許多血壓監測設備領域的領先公司都位於該地區,這促進了市場的成長。

美國是北美乃至全球血壓監測設備市場的最大貢獻者。冠心病是美國居民死亡的主要原因之一。作為北美乃至全球最大的經濟體,美國的人口趨勢對該地區市場有著顯著的影響,既有正面的一面,也有負面的一面。老齡人口的不斷成長意味著該國對患者監測設備的需求將不斷增加。

血壓監測設備市場報告範圍產業發展與未來機會:血壓監測設備市場領導企業的主要舉措包括:

2023年1月,Valencell在數位健康領域推出了自有品牌產品線,其首款產品旨在透過一款直覺的應用程式搭配一款創新的非處方藥(OTC)設備,幫助患者監測和管理高血壓,該設備無需袖帶或校準,即可透過手指精確測量血壓。 2022年10月,歐姆龍醫療將其血壓監測器產品組合升級為「互聯」設備。此次重大升級旨在為使用者和醫療保健專業人員提供無縫、即時且精準的高血壓管理。這些互聯設備可透過OMRON Connect應用程式輕鬆傳輸資料。競爭格局與關鍵參與者:血壓監測設備市場的知名公司包括歐姆龍醫療、偉倫公司、A&D醫療公司、順泰醫療公司、美國診斷公司、Withings、通用電氣醫療集團、邁科生命科技、GF健康產品公司、Spacelabs醫療保健和百特公司。這些公司專注於推進技術、改進現有產品並擴大地域範圍以滿足日益成長的全球消費者需求。

目錄

第1章:簡介

第2章:執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章:研究方法

第4章:血壓監測設備市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章:血壓監測設備市場-關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章:血壓監測設備市場-全球市場分析

  • 血壓監測設備 - 全球市場概覽
  • 血壓監測設備-全球市場及2030年預測

第7章:血壓監測設備市場-收入分析-依產品,2020-2030

  • 概述
  • 水銀柱
  • 無液體血壓計
  • 電子血壓計

第 8 章:血壓監測設備市場 - 收入分析 - 按類型,2020-2030 年

  • 概述
  • 手臂
  • 手腕
  • 手指
  • 其他

第9章:血壓監測設備市場-收入分析-按最終用戶,2020-2030

  • 概述
  • 醫院和診所
  • 家庭護理設置
  • 門診手術中心
  • 其他

第 10 章:血壓監測設備市場 - 收入分析,2020-2030 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章:產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 12 章:競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 13 章:血壓監測設備市場 - 主要公司簡介

  • Omron Healthcare
  • Welch Allyn, Inc.
  • A&D Medical Inc.
  • SunTech Medical, Inc.
  • American Diagnostics Corp
  • Withings
  • GE Healthcare
  • Microlife AG
  • GF Health Products, Inc.
  • Spacelabs Healthcare
  • Baxter

第 14 章:附錄

簡介目錄
Product Code: TIPMD00002666

The blood pressure monitoring devices market is anticipated to expand from US$ 2.91 billion in 2024 to US$ 5.90 billion by 2031, with an estimated CAGR of 10.6% from 2025 to 2031.

Market Insights and Analyst Perspective:Blood pressure monitoring devices are essential for identifying hypertension in patients. High blood pressure is a significant risk factor for strokes and chronic heart diseases, which are leading causes of mortality globally. Recently, there has been a notable increase in the adoption of blood pressure monitoring devices in home care environments. Additionally, factors such as an aging population, lifestyle changes, and technological innovations are key contributors to the growth of the blood pressure monitoring devices market. These devices enable early detection of health deterioration in patients. Furthermore, advanced personal blood pressure monitors allow for remote health tracking.

Growth Catalysts:Rising Incidence of Cardiovascular Diseases Fuels Growth in Blood Pressure Monitoring Devices Market

Over the past decade, significant advancements in blood pressure monitoring devices have provided patients and healthcare providers with innovative ways to manage various conditions, including ventricular and atrial arrhythmias, as well as ventricular atrial fibrillation. The increasing prevalence of cardiovascular diseases (CVDs) such as sudden cardiac arrest, coronary heart disease, congenital heart defects, pulmonary hypertension, heart failure, and elevated pulmonary artery pressure (PA) supports the development of enhanced monitoring techniques. The ease of use and rapid detection of irregularities are critical advantages of blood pressure monitoring devices. According to the World Health Organization (WHO), approximately 30 million individuals experience strokes annually. The American Heart Association projects that over 130 million people in the US will have some form of CVD by 2035.

The European Society of Cardiology reports that atrial fibrillation is the most prevalent arrhythmia, accounting for 0.28% to 2.6% of healthcare expenditures in Europe. It also indicates that patients with atrial fibrillation face a fivefold increased risk of stroke, with 20% to 30% of all stroke cases in Europe attributed to this condition. A 2016 study by the European Society of Cardiology found that around 7.6 million individuals aged 65 and older in the EU had atrial fibrillation, with projections suggesting this number could rise by 89% to approximately 14.4 million by 2060. The prevalence of atrial fibrillation is expected to increase from 7.8% in 2016 to 9.5% by 2060. According to a 2019 report by Biosense Webster titled "The Impact of Atrial Fibrillation in Asia Pacific," around 16 million people in the Asia Pacific region suffer from atrial fibrillation, with estimates suggesting this could rise to nearly 72 million by 2050. The report highlights that middle-aged and elderly populations are at a higher risk of developing this condition.

Strategic Insights

Report Segmentation and Scope:The "Blood Pressure Monitoring Devices Market" is categorized based on product, type, and end users. In terms of product, the market includes mercury columns, aneroid blood pressure monitors, and digital blood pressure monitors. By type, the market is divided into arm, wrist, finger, and others. For end users, the market is segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others.

Segmental Analysis:In terms of product, the blood pressure monitoring devices market is divided into mercury columns, aneroid blood pressure monitors, and digital blood pressure monitors. In 2022, the digital blood pressure segment captured a significant market share and is projected to exhibit the fastest CAGR from 2022 to 2030. Digital blood pressure devices are designed for precision and accuracy in measuring blood pressure and pulse. They are generally easier to operate than aneroid monitors, featuring a stethoscope and gauge in one unit, along with an error indicator. The blood pressure readings are displayed on a small screen, making them easier to read than traditional dials. Digital monitors are particularly beneficial for hearing-impaired patients, as they do not require listening to heartbeats through a stethoscope.

By type, the blood pressure monitoring devices market is categorized into arm, wrist, finger, and others. In 2022, the arm segment held the largest market share and is expected to grow at the fastest CAGR from 2022 to 2030. Finger-based blood pressure monitoring technology operates similarly to pulse oximetry, utilizing light that reflects off the user's finger to assess blood flow through a photoplethysmogram (PPG) interpreted by various algorithms. In May 2023, engineers at the University of California San Diego introduced a low-cost clip that uses a smartphone's camera and flash to measure blood pressure at the fingertip. This device, which works with a custom app, currently costs about 80 cents to produce, with potential costs dropping to 10 cents per unit at scale. This innovation aims to simplify and make regular blood pressure monitoring affordable and accessible, particularly for older adults and pregnant women managing hypertension.

Regarding end users, the blood pressure monitoring devices market is segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held a substantial market share, while the home care settings segment is projected to experience the fastest CAGR from 2022 to 2030. Hospitals and clinics serve as the primary healthcare providers in many regions. The American Heart Association, Inc. reports that the prevalence of rhythm abnormalities among middle-aged and older adults is significant. Conditions such as atrial fibrillation, bradyarrhythmia, and conduction system diseases represent the majority of abnormal rhythm cases. For instance, cardiac arrhythmias affect at least 2.3 million individuals in the US, increasing the risk of stroke and mortality. Additionally, 90,000 cases of supraventricular tachycardia are diagnosed annually in the US, accounting for 25% of all emergency department visits for this condition. An NCBI report indicates that 2,020 (36.1%) out of 5,585 hospital admissions for cardiac arrhythmias involved concurrent arrhythmias. Thus, the growing number of multispecialty hospitals and the preference for hospitals and clinics over other healthcare facilities contribute to the expansion of the blood pressure monitoring devices market in this segment.

Regional Analysis:Geographically, the global blood pressure monitoring devices market is divided into Asia Pacific, Europe, Middle East & Africa, North America, and South & Central America. In 2022, North America held the largest share of the global blood pressure monitoring devices market, while Asia Pacific is expected to achieve the highest CAGR from 2022 to 2030.

The North American blood pressure monitoring devices market comprises the US, Canada, and Mexico. The market's growth in this region is driven by factors such as the rising incidence of cardiac diseases and ongoing research and development aimed at creating innovative sensor-based patient monitoring systems. Furthermore, many leading companies in the blood pressure monitoring devices sector are based in this region, facilitating market growth.

The US is the largest contributor to the blood pressure monitoring devices market both in North America and globally. Coronary heart disease is a leading cause of death in the US. As the largest economy in North America and the world, demographic trends in the US significantly influence the regional market, both positively and negatively. The increasing elderly population suggests a higher demand for patient monitoring equipment in the country.

Blood Pressure Monitoring Devices Market Report Scope

Industry Developments and Future Opportunities:Key initiatives by leading players in the blood pressure monitoring devices market include:

In January 2023, Valencell launched its own branded product line in the Digital Health sector, with its first product aimed at helping patients monitor and manage hypertension through an intuitive app paired with an innovative OTC device that accurately measures blood pressure from the finger without the need for a cuff or calibration.

In October 2022, OMRON Healthcare enhanced its blood pressure monitor portfolio by converting them into "connected" devices. This significant upgrade was designed to provide users and healthcare professionals with seamless, real-time, and accurate hypertension management. The connected devices enable effortless data transfer through the OMRON Connect application.

Competitive Landscape and Key Players:Prominent companies in the blood pressure monitoring devices market include Omron Healthcare, Welch Allyn, Inc., A&D Medical Inc., SunTech Medical, Inc., American Diagnostics Corp., Withings, GE Healthcare, Microlife AG, GF Health Products, Inc., Spacelabs Healthcare, and Baxter. These companies are focused on advancing technologies, enhancing existing products, and expanding geographically to meet the growing global consumer demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Blood Pressure Monitoring Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Blood Pressure Monitoring Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Blood Pressure Monitoring Devices Market - Global Market Analysis

  • 6.1 Blood Pressure Monitoring Devices - Global Market Overview
  • 6.2 Blood Pressure Monitoring Devices - Global Market and Forecast to 2030

7. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million) - By Product, 2020-2030

  • 7.1 Overview
  • 7.2 Mercury Columns
  • 7.3 Aneroid Blood Pressure Monitors
  • 7.4 Digital Blood Pressure Monitors

8. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 8.1 Overview
  • 8.2 Arm
  • 8.3 Wrist
  • 8.4 Finger
  • 8.5 Others

9. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
  • 9.3 Homecare Settings
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Others

10. Blood Pressure Monitoring Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Blood Pressure Monitoring Devices Market Overview
    • 10.1.2 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts to 2030
    • 10.1.3 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By Product
    • 10.1.4 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By Type
    • 10.1.5 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Blood Pressure Monitoring Devices Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Blood Pressure Monitoring Devices Market
        • 10.1.6.1.1 United States Blood Pressure Monitoring Devices Market, by Product
        • 10.1.6.1.2 United States Blood Pressure Monitoring Devices Market, by Type
        • 10.1.6.1.3 United States Blood Pressure Monitoring Devices Market, by End User
      • 10.1.6.2 Canada Blood Pressure Monitoring Devices Market
        • 10.1.6.2.1 Canada Blood Pressure Monitoring Devices Market, by Product
        • 10.1.6.2.2 Canada Blood Pressure Monitoring Devices Market, by Type
        • 10.1.6.2.3 Canada Blood Pressure Monitoring Devices Market, by End User
      • 10.1.6.3 Mexico Blood Pressure Monitoring Devices Market
        • 10.1.6.3.1 Mexico Blood Pressure Monitoring Devices Market, by Product
        • 10.1.6.3.2 Mexico Blood Pressure Monitoring Devices Market, by Type
        • 10.1.6.3.3 Mexico Blood Pressure Monitoring Devices Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Blood Pressure Monitoring Devices Market - Key Company Profiles

  • 13.1 Omron Healthcare
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Welch Allyn, Inc.
  • 13.3 A&D Medical Inc.
  • 13.4 SunTech Medical, Inc.
  • 13.5 American Diagnostics Corp
  • 13.6 Withings
  • 13.7 GE Healthcare
  • 13.8 Microlife AG
  • 13.9 GF Health Products, Inc.
  • 13.10 Spacelabs Healthcare
  • 13.11 Baxter

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud